A Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab

Trial Profile

A Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2018

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PROSPERO
  • Sponsors Roche
  • Most Recent Events

    • 05 Mar 2018 Results presented at the 2018 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
    • 17 Oct 2017 Results assessing disease and comorbidity burden characteristics published in the Annals of Allergy, Asthma and Immunology
    • 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top